Pinnacle Financial Partners Inc Bristol Myers Squibb CO Transaction History

Pinnacle Financial Partners Inc

$4.89 Billion
Q4 2024

A detailed history of Pinnacle Financial Partners Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pinnacle Financial Partners Inc holds 361,318 shares of BMY stock, worth $22.1 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

361,318

Previous 363,443 0.58%

Holding current value

$22.1 Million

Previous $18.8 Million 8.66%

% of portfolio

0.42%

Previous 0.38%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 03, 2025	SELL	$51.92 - $59.94 $110,330 - $127,372	-2,125 Reduced 0.58%	361,318 $20.4 Million
Q3 2024 Nov 05, 2024	BUY	$39.66 - $51.75 $10.8 Million - $14.1 Million	272,439 Added 299.37%	363,443 $18.8 Million
Q2 2024 Aug 06, 2024	BUY	$40.25 - $52.99 $1.72 Million - $2.26 Million	42,725 Added 88.5%	91,004 $3.78 Million
Q1 2024 Apr 30, 2024	SELL	$47.98 - $54.4 $30,323 - $34,380	-632 Reduced 1.29%	48,279 $2.62 Million
Q4 2023 Jan 22, 2024	SELL	$48.48 - $57.85 $11,004 - $13,131	-227 Reduced 0.46%	48,911 $2.51 Million
Q3 2023 Nov 03, 2023	SELL	$57.89 - $64.73 $270,404 - $302,353	-4,671 Reduced 8.68%	49,138 $2.85 Million
Q2 2023 Aug 07, 2023	SELL	$63.71 - $70.74 $64,283 - $71,376	-1,009 Reduced 1.84%	53,809 $3.44 Million
Q1 2023 Apr 26, 2023	BUY	$65.71 - $74.53 $251,209 - $284,928	3,823 Added 7.5%	54,818 $3.8 Million
Q4 2022 Feb 03, 2023	SELL	$68.48 - $81.09 $366,436 - $433,912	-5,351 Reduced 9.5%	50,995 $3.67 Million
Q3 2022 Oct 31, 2022	BUY	$0.13 - $76.84 $167 - $98,816	1,286 Added 2.34%	56,346 $4.01 Million
Q2 2022 Jul 29, 2022	BUY	$72.62 - $79.98 $637,530 - $702,144	8,779 Added 18.97%	55,060 $4.24 Million
Q1 2022 May 02, 2022	SELL	$61.48 - $73.72 $33,322 - $39,956	-542 Reduced 1.16%	46,281 $3.38 Million
Q4 2021 Feb 01, 2022	BUY	$53.63 - $62.52 $155,473 - $181,245	2,899 Added 6.6%	46,823 $2.92 Million
Q3 2021 Oct 26, 2021	SELL	$59.17 - $69.31 $101,713 - $119,143	-1,719 Reduced 3.77%	43,924 $2.6 Million
Q2 2021 Jul 21, 2021	BUY	$61.91 - $67.42 $243,244 - $264,893	3,929 Added 9.42%	45,643 $3.05 Million
Q1 2021 Apr 19, 2021	SELL	$59.34 - $66.74 $213,802 - $240,464	-3,603 Reduced 7.95%	41,714 $2.63 Million
Q4 2020 Jan 13, 2021	BUY	$57.74 - $65.43 $17,033 - $19,301	295 Added 0.66%	45,317 $2.81 Million
Q3 2020 Oct 27, 2020	SELL	$57.43 - $63.64 $253,668 - $281,097	-4,417 Reduced 8.93%	45,022 $2.72 Million
Q2 2020 Jul 28, 2020	SELL	$54.82 - $64.09 $50,653 - $59,219	-924 Reduced 1.83%	49,439 $2.91 Million
Q1 2020 Apr 16, 2020	SELL	$46.4 - $67.43 $54,520 - $79,230	-1,175 Reduced 2.28%	50,363 $2.81 Million
Q4 2019 Feb 06, 2020	BUY	$49.21 - $64.19 $101,224 - $132,038	2,057 Added 4.16%	51,538 $3.31 Million
Q3 2019 Oct 25, 2019	BUY	$42.77 - $50.71 $199,607 - $236,663	4,667 Added 10.41%	49,481 $2.51 Million
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $99,056 - $109,534	2,220 Added 5.21%	44,814 $2.03 Million
Q1 2019 May 02, 2019	SELL	$45.12 - $53.8 $54,865 - $65,420	-1,216 Reduced 2.78%	42,594 $2.03 Million
Q4 2018 Feb 04, 2019	SELL	$48.76 - $63.23 $99,421 - $128,925	-2,039 Reduced 4.45%	43,810 $2.28 Million
Q3 2018 Oct 31, 2018	BUY	$55.19 - $62.25 $10,762 - $12,138	195 Added 0.43%	45,849 $2.85 Million
Q2 2018 Jul 27, 2018	BUY	$50.53 - $62.98 $186,354 - $232,270	3,688 Added 8.79%	45,654 $2.53 Million
Q1 2018 May 03, 2018	SELL	$59.92 - $68.98 $18,035 - $20,762	-301 Reduced 0.71%	41,966 $2.65 Million
Q4 2017 Feb 08, 2018	SELL	$59.94 - $65.35 $63,896 - $69,663	-1,066 Reduced 2.46%	42,267 $2.59 Million
Q3 2017 Nov 08, 2017	BUY	$55.23 - $63.74 $2.39 Million - $2.76 Million	43,333	43,333 $2.76 Million

Others Institutions Holding BMY

# of Institutions

2,765

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $130B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Financial Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Financial Partners Inc with notifications on news.

Account

Pinnacle Financial Partners Inc Bristol Myers Squibb CO Transaction History